D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 78 Citations 26,025 384 World Ranking 12735 National Ranking 649

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Radiology

His main research concerns Surgery, Angioplasty, Restenosis, Stent and Randomized controlled trial. Surgery is frequently linked to Radiology in his study. His studies deal with areas such as Lesion, Multicenter trial, Amputation, Revascularization and Aortic stent as well as Angioplasty.

His studies in Restenosis integrate themes in fields like Contrast medium, Stenosis, Vascular disease and Target lesion. His Drug-eluting stent study in the realm of Stent interacts with subjects such as False lumen. While the research belongs to areas of Randomized controlled trial, Thomas Zeller spends his time largely on the problem of Blood pressure, intersecting his research to questions surrounding Ambulatory, Catheter, Intensive care medicine and Kidney.

His most cited work include:

  • Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial (1869 citations)
  • Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. (684 citations)
  • Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length The Femoral Artery Stenting Trial (FAST) (418 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Surgery, Angioplasty, Radiology, Stent and Restenosis. His research combines Revascularization and Surgery. His Angioplasty study integrates concerns from other disciplines, such as Lesion, Critical limb ischemia and Femoral artery.

Thomas Zeller specializes in Stent, namely Drug-eluting stent. His research integrates issues of Prospective cohort study, Claudication, Clinical endpoint and Vascular Patency in his study of Restenosis. His biological study deals with issues like Denervation, which deal with fields such as Catheter.

He most often published in these fields:

  • Surgery (59.38%)
  • Angioplasty (36.46%)
  • Radiology (31.77%)

What were the highlights of his more recent work (between 2017-2021)?

  • Surgery (59.38%)
  • Angioplasty (36.46%)
  • Balloon (20.31%)

In recent papers he was focusing on the following fields of study:

Thomas Zeller focuses on Surgery, Angioplasty, Balloon, Randomized controlled trial and Stent. His Surgery research includes themes of Adverse effect, Clinical trial and Revascularization. His Angioplasty study incorporates themes from Drug coated balloon, Restenosis, Intermittent claudication and Lesion.

He has researched Balloon in several fields, including Sirolimus, Artery, Excipient and Paclitaxel coated balloon. Thomas Zeller has included themes like Percutaneous and Incidence in his Randomized controlled trial study. His Stent study is related to the wider topic of Radiology.

Between 2017 and 2021, his most popular works were:

  • Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial (256 citations)
  • Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon. (118 citations)
  • Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. (79 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Radiology

The scientist’s investigation covers issues in Surgery, Randomized controlled trial, Angioplasty, Balloon and Adverse effect. His Popliteal artery, Stent and Critical limb ischemia study in the realm of Surgery connects with subjects such as Target lesion revascularization. His research in Randomized controlled trial intersects with topics in Restenosis, Percutaneous and Arterial disease.

His Angioplasty research is multidisciplinary, relying on both Intermittent claudication, Stenosis and Amputation. The study incorporates disciplines such as Meta-analysis, Clinical trial and Revascularization in addition to Balloon. His Adverse effect research integrates issues from Peripheral, Anesthesia, Blood pressure and Denervation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial

Murray D. Esler;Henry Krum;Paul A. Sobotka;Markus P. Schlaich.
The Lancet (2010)

3289 Citations

Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.

Gunnar Tepe;Thomas Zeller;Thomas Albrecht;Stephan Heller.
The New England Journal of Medicine (2008)

890 Citations

Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length The Femoral Artery Stenting Trial (FAST)

Hans Krankenberg;Michael Schlüter;Hermann J. Steinkamp;Karlheinz Bürgelin.
Circulation (2007)

686 Citations

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Raymond R Townsend;Felix Mahfoud;Felix Mahfoud;David E Kandzari;Kazuomi Kario.
The Lancet (2017)

654 Citations

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease 12-Month Results From the IN.PACT SFA Randomized Trial

Gunnar Tepe;John Laird;Peter Schneider;Marianne Brodmann.
Circulation (2015)

652 Citations

Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease Twelve-Month Zilver PTX Randomized Study Results

Michael D. Dake;Gary M. Ansel;Michael R. Jaff;Takao Ohki.
Circulation-cardiovascular Interventions (2011)

620 Citations

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

David E Kandzari;Michael Böhm;Felix Mahfoud;Felix Mahfoud;Raymond R Townsend.
The Lancet (2018)

592 Citations

Medial vascular calcification revisited: review and perspectives

Peter Lanzer;Manfred Boehm;Victor Sorribas;Marc Thiriet.
European Heart Journal (2014)

589 Citations

Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.

Stephan H. Duda;Stephan H. Duda;Marc Bosiers;Johannes Lammer;Dierk Scheinert.
Journal of Endovascular Therapy (2006)

585 Citations

Expert consensus document from the European Society of Cardiology on catheter-based renal denervation

Felix Mahfoud;Thomas Felix Lüscher;Bert Andersson;Iris Baumgartner.
European Heart Journal (2013)

540 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas Zeller

Markus P. Schlaich

Markus P. Schlaich

University of Western Australia

Publications: 138

Michael R. Jaff

Michael R. Jaff

Boston Scientific (United States)

Publications: 97

Roland E. Schmieder

Roland E. Schmieder

University of Erlangen-Nuremberg

Publications: 86

Murray D. Esler

Murray D. Esler

Baker IDI Heart and Diabetes Institute

Publications: 79

Michael Böhm

Michael Böhm

Saarland University

Publications: 72

Michael Böhm

Michael Böhm

Saarland University

Publications: 69

Christopher J. White

Christopher J. White

University of Queensland

Publications: 62

Sverre E. Kjeldsen

Sverre E. Kjeldsen

University of Oslo

Publications: 43

Deepak L. Bhatt

Deepak L. Bhatt

Brigham and Women's Hospital

Publications: 42

Raymond R. Townsend

Raymond R. Townsend

University of Pennsylvania

Publications: 40

Jan A. Staessen

Jan A. Staessen

KU Leuven

Publications: 39

Elazer R. Edelman

Elazer R. Edelman

MIT

Publications: 38

Thomas F. Lüscher

Thomas F. Lüscher

University of Zurich

Publications: 36

Renu Virmani

Renu Virmani

CVPath Institute

Publications: 35

Henry Krum

Henry Krum

Monash University

Publications: 32

Manesh R. Patel

Manesh R. Patel

Duke University

Publications: 32

Trending Scientists

Daniel D. Gajski

Daniel D. Gajski

University of California, Irvine

E. Philip Davis

E. Philip Davis

Brunel University London

Sudip K. Mazumder

Sudip K. Mazumder

University of Illinois at Chicago

Hongqiang Wang

Hongqiang Wang

Guangxi Normal University

James P. Ferris

James P. Ferris

Rensselaer Polytechnic Institute

Christophe Thébaud

Christophe Thébaud

Paul Sabatier University

Franklin Riet-Correa

Franklin Riet-Correa

Federal University of Campina Grande

Tarek A. Ebeid

Tarek A. Ebeid

Kafrelsheikh University

Janis K. Burkhardt

Janis K. Burkhardt

University of Pennsylvania

Mang Shi

Mang Shi

Sun Yat-sen University

Brita Robertson

Brita Robertson

Karolinska Institute

Klaus Oberauer

Klaus Oberauer

University of Zurich

Alexandra Loukas

Alexandra Loukas

The University of Texas at Austin

Robert W. Levenson

Robert W. Levenson

University of California, Berkeley

Jörg Hausleiter

Jörg Hausleiter

Ludwig-Maximilians-Universität München

Glen Bramley

Glen Bramley

Heriot-Watt University

Something went wrong. Please try again later.